World News: 13:15 GMT Thursday 2nd May 2019. [XBiotech Inc. via Globe Newswire via SPi World News]
AUSTIN Texas May 02 2019 GLOBE NEWSWIRE --Inc NASDAQ XBIT announced today enrollment of the final into its Phase I study evaluating bermekimab in patients with advanced pancreatic adenocarcinoma and The study i s being...
Globe Newswire: 13:15 GMT Thursday 2nd May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.